FDA Narrowed "Disease" Definition Expands Structure/Function Claims
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement manufacturers will be able to make expanded structure/function claims on product labeling under an FDA final rule published in the Jan. 6 Federal Register. The rule clarifies the distinction between structure/function and disease claims by reverting to the older, narrower definition of "disease" used in the Nutrition Labeling & Education Act.